Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1986 Mar;39(3):332–334. doi: 10.1136/jcp.39.3.332

Micromodification of Serodia HBe haemagglutination kit and modification of kit to test for anti-HBe.

P A Nuttall
PMCID: PMC499773  PMID: 3958219

Abstract

Modification of the Serodia HBe haemagglutination kit produced by Fujirebio Incorporated, Tokyo, Japan, gave a rapid, economical, and easily performed test for hepatitis Be antigen (HBeAg). The use of this method to test serum samples for HBeAg is described. A modification of the kit to screen for anti-HBe is also described. The results obtained showed that this kit, when used by the method described, gave results comparable with those of a sensitive, commercial enzyme immunoassay method.

Full text

PDF
332

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baraldini M., Facchini A., Miglio F., Ramadori G., Alberti A., Realdi G. Radioimmunoassay for hepatitis B 'e' antigen and antibody: correlations with viral replication and prognostic value. Vox Sang. 1981 Sep;41(3):139–145. doi: 10.1111/j.1423-0410.1981.tb01027.x. [DOI] [PubMed] [Google Scholar]
  2. Beasley R. P., Hwang L. Y., Lee G. C., Lan C. C., Roan C. H., Huang F. Y., Chen C. L. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983 Nov 12;2(8359):1099–1102. doi: 10.1016/s0140-6736(83)90624-4. [DOI] [PubMed] [Google Scholar]
  3. Beasley R. P., Hwang L. Y., Lin C. C., Stevens C. E., Wang K. Y., Sun T. S., Hsieh F. J., Szmuness W. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial. Lancet. 1981 Aug 22;2(8243):388–393. doi: 10.1016/s0140-6736(81)90832-1. [DOI] [PubMed] [Google Scholar]
  4. Mushahwar I. K., Overby L. R. An enzyme immunoassay for hepatitis B e-antigen and antibody. J Virol Methods. 1981 Sep;3(2):89–97. doi: 10.1016/0166-0934(81)90005-7. [DOI] [PubMed] [Google Scholar]
  5. Puska P., Iacono J. M., Nissinen A., Korhonen H. J., Vartianinen E., Pietinen P., Dougherty R., Leino U., Mutanen M., Moisio S. Controlled, randomised trial of the effect of dietary fat on blood pressure. Lancet. 1983 Jan 1;1(8314-5):1–5. doi: 10.1016/s0140-6736(83)91556-8. [DOI] [PubMed] [Google Scholar]
  6. Stevens C. E., Neurath R. A., Beasley R. P., Szmuness W. HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol. 1979;3(3):237–241. doi: 10.1002/jmv.1890030310. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES